brl 42810 has been researched along with Chronic Hepatitis C in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Due to its low efficacy, 40% in the treatment of chronic hepatitis B and 10-20% in the treatment of chronic hepatitis C, and to its adverse events, in some cases severe, new antiviric molecules are being investigated." | 2.40 | [New antiviral agents in the treatment of chronic hepatitis B and C]. ( Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olaso Peiró, V | 1 |
| López Viedma, B | 1 |
| Córdoba Cortijo, J | 1 |
| Main, J | 1 |
| McCarron, B | 1 |
| Thomas, HC | 1 |
| Zavaglia, C | 1 |
| Airoldi, A | 1 |
| Pinzello, G | 1 |
3 reviews available for brl 42810 and Chronic Hepatitis C
| Article | Year |
|---|---|
[New antiviral agents in the treatment of chronic hepatitis B and C].
Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B | 1998 |
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models | 1998 |
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic | 2000 |